Silence Therapeutics Market Sentiment

Silence Therapeutics PLC

SLNNASDAQ

Trade with Public

$19.67

0.060.31%

Dern. MÀJ: Oct 21, 7:54 PM

$19.64

0.030.15%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentComparer Options Rapport sur les stocks

Fusions et acquisitions: Silence Therapeutics (SLN) announced it will be acquired by Merck KGaA on Monday, October 19, 2026 for $1.1B paid in cash

Silence Therapeutics Market Sentiment - Benzinga

Silence Therapeutics Market Sentiment

Market sentiment signals for Silence Therapeutics (SLN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 5.0% short float

Options Flow▲ 0.09 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

7 analysts

Options Flow (P/C)

0.09

More calls — Bullish

261 calls · 23 puts

Avg Consensus PT

$32

+61.3%

Highest Price Target

$75

+281.9%

HC Wainwright & Co.

Lowest Price Target

-84.7%

Goldman Sachs

Short Interest

5.0%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+1.8%	$75 → $20	Downgrade	Buy→Neutral
Aug 11, 2026	Morgan Stanley	Michael Ulz—	+62.9%	$25 → $32	Maintained	Overweight
Jun 24, 2026	Cantor Fitzgerald	Prakhar Agrawal—	—	—	Initiate	Overweight
Jun 17, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Mar 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Sep 16, 2025	HC Wainwright & Co.	Patrick R. Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Aug 8, 2025	Chardan Capital	Keay Nakae—	+78.2%	$35 → $35	Maintained	Buy
Jun 13, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Jun 13, 2025	Chardan Capital	Keay Nakae—	+78.2%	$35 → $35	Maintained	Buy
May 9, 2025	Goldman Sachs	Richard Law—	-84.7%	$4 → $3	Maintained	Sell
May 9, 2025	Morgan Stanley	Michael Ulz—	+27.3%	$45 → $25	Maintained	Overweight
May 9, 2025	Chardan Capital	Keay Nakae—	+78.2%	$55 → $35	Maintained	Buy
Mar 7, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Mar 5, 2025	Morgan Stanley	Michael Ulz—	+129.1%	$49 → $45	Maintained	Overweight
Mar 4, 2025	BMO Capital	Kostas Biliouris—	+27.3%	$67 → $25	Maintained	Outperform
Mar 4, 2025	Goldman Sachs	Richard Law—	-79.6%	$6 → $4	Maintained	Sell
Feb 11, 2025	Goldman Sachs	Richard Law—	-69.5%	$6	Initiate	Sell
Feb 3, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Jan 29, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Dec 10, 2024	Chardan Capital	Keay Nakae—	+180.0%	$55 → $55	Maintained	Buy
Dec 9, 2024	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Nov 20, 2024	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Patrick Trucchio—	+281.9%	$75 → $75	Maintained	Buy
Nov 14, 2024	Chardan Capital	Keay Nakae—	+180.0%	$55 → $55	Maintained	Buy
Oct 8, 2024	Morgan Stanley	Michael Ulz—	+149.5%	$49 → $49	Maintained	Overweight